Menopause Hormone Therapy: Understanding the Benefits, Risks
If you've started looking into menopause hormone therapy (MHT), you've probably noticed that there are a lot of conflicting opinions online.
Some articles describe it as life-changing. Others still warn that it's dangerous.
So which is true?
The reality is that our understanding of menopause hormone therapy has changed dramatically over the past two decades. Much of the fear surrounding MHT can be traced back to a single study published in 2002. Since then, researchers have learned a tremendous amount about who benefits from hormone therapy, when it should be started, and how different types of hormones affect health.
Today, menopause hormone therapy is considered the most effective treatment for many symptoms of menopause and perimenopause. For many women, it also provides important long-term health benefits when started at the right time.
Why Hormone Levels Matter
During perimenopause and menopause, estrogen and progesterone levels decline.
These hormones do much more than regulate your menstrual cycle. They affect nearly every organ in the body, including the brain, heart, bones, muscles, skin, urinary tract, and vagina.
As hormone levels change, women may experience:
Hot flashes and night sweats
Brain fog
Mood changes and anxiety
Sleep disruption
Vaginal dryness and painful intercourse
Urinary urgency or recurrent UTIs
Joint aches
Fatigue
Reduced muscle mass
Changes in cholesterol and cardiovascular health
Bone loss
For many women, replacing hormones simply restores the hormone levels the body has gradually lost.
The Benefits of Menopause Hormone Therapy
For women who are appropriate candidates, menopause hormone therapy offers benefits that extend well beyond symptom relief.
It is the most effective treatment for hot flashes and night sweats.
Hormone therapy reduces both the frequency and severity of vasomotor symptoms far better than non-hormonal medications.
It improves sleep.
Many women notice they sleep better once hot flashes improve. Estrogen and progesterone also have direct effects on sleep regulation, helping many women achieve deeper, more restorative sleep.
It supports brain function.
Many women describe feeling like they "have their brain back" after starting treatment. Estrogen plays an important role in attention, memory, processing speed, and cognitive function. While MHT is not a treatment for dementia, it can significantly improve the brain fog that commonly develops during perimenopause.
It improves mood.
Hormonal fluctuations can contribute to anxiety, irritability, and low mood. For many women, stabilizing estrogen levels helps them feel more emotionally like themselves again.
It protects bone health.
Estrogen slows bone loss and significantly reduces the risk of osteoporosis and fractures. This becomes increasingly important after menopause, when bone density can decline rapidly.
It improves vaginal and urinary health.
Low estrogen affects the tissues of the vagina, vulva, bladder, and urethra. Hormone therapy, particularly vaginal estrogen, can improve dryness, painful intercourse, urinary urgency, recurrent urinary tract infections, and other symptoms of genitourinary syndrome of menopause (GSM).
It may reduce the risk of cardiovascular disease when started early.
This surprises many people.
Current evidence suggests that women who begin hormone therapy before age 60, or within 10 years of menopause, may have improved cardiovascular outcomes compared with women who do not use hormone therapy. This concept is known as the "timing hypothesis" or "window of opportunity."
What Happened in 2002?
If you've heard that hormone therapy causes breast cancer or heart attacks, you're probably thinking of the Women's Health Initiative (WHI).
When the initial results were released in 2002, media headlines understandably alarmed both physicians and patients. Millions of women stopped taking hormone therapy almost overnight.
The problem is that the study was widely misunderstood.
The average woman enrolled in the WHI was 63 years old, more than a decade past menopause. Many participants already had cardiovascular risk factors, obesity, or underlying vascular disease. This is very different from the average woman who starts hormone therapy today, who is often in her late 40s or early 50s and experiencing new menopausal symptoms.
The study also evaluated oral conjugated equine estrogens (derived from horse urine) and a synthetic progestin called medroxyprogesterone acetate. These are different from the bioidentical estradiol and micronized progesterone that are commonly prescribed today.
Another issue was how the results were communicated. The reported increases in risk were often presented as relative risk, which sounds much more dramatic than the actual numbers. For example, a "26% increase" in breast cancer translated to approximately 8 additional cases per 10,000 women per year, not hundreds of women developing cancer.
Over the past 20 years, reanalysis of the WHI data and numerous additional studies have shown that the risks depend heavily on a woman's age, overall health, when therapy is started, and which hormones are used.
The message from the WHI was never that hormone therapy is unsafe for everyone. Unfortunately, that is how many people interpreted it.
What Are the Risks?
Like any medication, menopause hormone therapy is not completely risk-free.
The good news is that for healthy women who begin treatment before age 60 or within 10 years of menopause, serious complications are uncommon.
The main risks depend on the type of hormone used, the dose, the route of administration, and your personal medical history.
Blood clots
Oral estrogen slightly increases the risk of blood clots because it passes through the liver before entering the bloodstream.
Transdermal estrogen, such as patches, gels, or sprays, largely avoids this effect and appears to have little or no increased risk of blood clots in healthy women.
Stroke
Stroke risk increases naturally with age. In younger women who start hormone therapy during the window of opportunity, the absolute risk remains very low.
Breast cancer
This is often the biggest concern.
Current evidence suggests that estrogen alone does not increase breast cancer risk in women who have had a hysterectomy.
When progesterone is needed to protect the uterus, the type of progesterone matters. Micronized progesterone appears to have a more favourable breast safety profile than older synthetic progestins, although ongoing research continues.
It is also important to remember that many everyday factors have a similar or greater effect on breast cancer risk than hormone therapy, including obesity, alcohol consumption, and physical inactivity.
Who Should Not Take Hormone Therapy?
Hormone therapy is not appropriate for everyone.
Women with certain medical conditions, including active breast cancer, unexplained vaginal bleeding, severe liver disease, or a history of certain blood clotting disorders, may need different treatment options.
This is why hormone therapy should always be individualized after reviewing your personal medical history, family history, symptoms, and treatment goals.
Conclusion
Menopause hormone therapy is one of the most studied treatments in medicine.
For the right patient, started at the right time, the benefits often outweigh the risks. It can dramatically improve quality of life while also protecting bone health and supporting long-term healthy aging.
The decision to use hormone therapy should never be based on outdated headlines from 2002. Instead, it should be based on today's evidence and an individualized discussion with a healthcare provider who stays current with menopause research.
If you're experiencing symptoms of perimenopause or menopause and wondering whether hormone therapy might be right for you, I'd be happy to help. During your visit, we'll review your symptoms, medical history, and risk factors to develop a treatment plan that fits your health goals and helps you feel like yourself again.